Wisp patients enrolled in its weight care program can now access nutrition counseling services with Nourish. The post Wisp Teams Up with Nourish to Combine GLP-1s with Nutrition Counseling appeared first on MedCity News.
SiteOne Therapeutics develops drugs that target sodium channels, the “wiring” in the body that transmits pain signals. Because SiteOne’s targets are located in the peripheral nervous system, they should not pose the same addiction risks as opioids, which hit receptors in the central nervous system. The post Startup SiteOne Secures $100M to Forge Ahead With…
Like any other tool, understanding the right problem to apply it to is the difference between success and failure. Addressing a problem is never just about technology; it’s always about people, processes, and technology. The post The AI Advantage: Reimagining the Future of Drug Development appeared first on MedCity News.
Four key predictions for the future of clinical trials, examining how these changes will revolutionize the speed, efficiency, and reliability of bringing life-saving treatments to market. The post Future Trends for Clinical Trials in 2025 and Beyond appeared first on MedCity News.
Discover the cutting-edge AI software that empowers trauma and critical care teams with real-time, data-driven insights. The post TraumaCare.AI shaping the future of critical care with AI-powered innovation appeared first on MedCity News.
This week, the FDA granted clearance to Withings’ BPM Pro 2 cellular blood pressure monitor. The device seeks to help providers scale remote patient monitoring for heart failure patients. The post FDA Clears Withings’ New Blood Pressure Monitor That Allows Providers to Communicate Directly with Patients appeared first on MedCity News.
WellTheory has launched a new program that will address the link between autoimmune disease and hormone imbalances. The post WellTheory Announces Women’s Health Program to Address Hormonal Conditions appeared first on MedCity News.
The Teva Pharmaceuticals and Sanofi drug, duvakitug, showed statistically significant and clinically meaningful results in a Phase 2b study in ulcerative colitis and Crohn’s disease. The drug is part of an emerging class of therapies that target TL1A, a protein involved in signaling that drives inflammation. The post Teva and Sanofi Mid-Stage Data Reveal Shows…
Telehealth empowers men to take control of their health in a way that is easy, confidential, and fits into their busy lifestyles. The post The Future of Men’s Healthcare: A Path to Improved Access, Outcomes, and Cost Savings appeared first on MedCity News.
Solutions like AI-powered patient intake offer a tangible ROI by streamlining administrative tasks, reducing errors, and improving care quality. The post Let’s Rethink AI — Patient Intake Is the Perfect Place to Start appeared first on MedCity News.